Diagnosis: Secondary Hyperparathyroidism Due to Vitamin D Deficiency
This patient has secondary hyperparathyroidism caused by severe vitamin D deficiency (17 ng/mL), not primary hyperparathyroidism, and the appropriate management is vitamin D repletion followed by reassessment after maintaining normal vitamin D levels for at least 6 months 1.
Diagnostic Reasoning
The biochemical pattern is classic for secondary hyperparathyroidism:
- Elevated PTH (186) with borderline calcium (10.5) indicates inappropriate PTH secretion
- Critically low vitamin D (17 ng/mL) is the driving factor
- Markedly low 24-hour urine calcium (27 mg/day, approximately 0.67 mmol/day) and low urine calcium/creatinine ratio (46 mg/g, approximately 0.005) indicate the kidneys are appropriately conserving calcium in response to vitamin D deficiency 1
The 2025 French Expert Consensus explicitly states that before accepting a diagnosis of primary hyperparathyroidism, you must rule out causes of secondary hyperparathyroidism by maintaining normal vitamin D levels long-term (>6 months) and screening for potential causes 1.
Key Differentiating Features
Why This is NOT Primary Hyperparathyroidism:
In typical PHPT, you expect:
- Hypercalcemia with elevated PTH
- Increased urine calcium or calcium excretion fraction 1
- Fractional excretion of calcium (FeCa) >2% 1
This patient has the opposite: profoundly suppressed urinary calcium excretion, indicating chronic negative calcium balance 2.
Why This is NOT Familial Hypocalciuric Hypercalcemia (FHH):
While the low urine calcium/creatinine ratio might suggest FHH:
- FHH typically presents with hypercalcemia (this patient is only borderline at 10.5)
- FHH patients have inappropriately normal or elevated PTH despite hypercalcemia, not elevated PTH driving borderline calcium
- The vitamin D deficiency fully explains this presentation 3, 4
Management Algorithm
Step 1: Vitamin D Repletion (Immediate)
- Correct vitamin D deficiency to >30 ng/mL
- Use ergocalciferol or cholecalciferol at appropriate loading doses
- Target: maintain 25(OH)D >30 ng/mL for at least 6 months 1
Step 2: Calcium Supplementation
- Add calcium supplementation during vitamin D repletion
- The profoundly low 24-hour urine calcium (27 mg/day vs normal >100 mg/day) indicates severe negative calcium balance 2
- Monitor serum calcium to avoid hypercalcemia during treatment
Step 3: Reassessment After 6+ Months
After maintaining normal vitamin D levels for >6 months, repeat:
- Serum calcium
- PTH
- 24-hour urine calcium
- Urine calcium/creatinine ratio
Expected outcome: PTH should normalize and urine calcium should increase once vitamin D is repleted 1, 5.
Step 4: If PTH Remains Elevated After Vitamin D Repletion
Only then consider:
- Oral calcium loading test (Pak test) to differentiate PHPT from other causes 1, 5
- Parathyroid imaging if PHPT is confirmed
- Genetic testing for FHH if calcium/creatinine clearance ratio remains <0.01 3, 4
Critical Pitfalls to Avoid
Do NOT proceed to parathyroid imaging or surgery without first correcting vitamin D deficiency 1. This is the most common error and can lead to unnecessary parathyroidectomy 4, 6.
Do NOT use a single urine calcium/creatinine ratio to diagnose FHH in the setting of vitamin D deficiency 3, 4. Vitamin D deficiency mimics FHH biochemically by causing hypocalciuria.
Do NOT accept a diagnosis of PHPT with 24-hour urine calcium this low (27 mg/day). This is far below the typical range for PHPT, where urine calcium is usually elevated 3.
The low 24-hour urine creatinine (0.59 g/day) suggests either incomplete collection or very low muscle mass. Verify collection adequacy before interpreting calcium excretion results.
Evidence Quality Note
The 2025 French Expert Consensus provides Grade A+ recommendations specifically addressing this clinical scenario, emphasizing that vitamin D deficiency must be corrected and maintained for >6 months before diagnosing primary hyperparathyroidism 1. This represents the highest quality, most recent guideline evidence available.